183 related articles for article (PubMed ID: 30831307)
21. Higher than standard dosing regimen are needed to achieve optimal antibiotic exposure in critically ill patients with augmented renal clearance receiving piperacillin-tazobactam administered by continuous infusion.
Carrié C; Legeron R; Petit L; Ollivier J; Cottenceau V; d'Houdain N; Boyer P; Lafitte M; Xuereb F; Sztark F; Breilh D; Biais M
J Crit Care; 2018 Dec; 48():66-71. PubMed ID: 30172963
[TBL] [Abstract][Full Text] [Related]
22. Suboptimal aminoglycoside dosing in critically ill patients.
Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
[TBL] [Abstract][Full Text] [Related]
23. Piperacillin Population Pharmacokinetics in Critically Ill Adults During Sustained Low-Efficiency Dialysis.
Kanji S; Roberts JA; Xie J; Alobaid A; Zelenitsky S; Hiremath S; Zhang G; Watpool I; Porteous R; Patel R
Ann Pharmacother; 2018 Oct; 52(10):965-973. PubMed ID: 29730948
[TBL] [Abstract][Full Text] [Related]
24. Alveolar and serum concentrations of imipenem in two lung transplant recipients supported with extracorporeal membrane oxygenation.
Welsch C; Augustin P; Allyn J; Massias L; Montravers P; Allou N
Transpl Infect Dis; 2015 Feb; 17(1):103-5. PubMed ID: 25572932
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of Amikacin in Critical Care Patients on Extracorporeal Device.
Ruiz-Ramos J; Gimeno R; Pérez F; Ramirez P; Villarreal E; Gordon M; Vicent C; Remedios Marqués M; Castellanos-Ortega Á
ASAIO J; 2018; 64(5):686-688. PubMed ID: 29045281
[TBL] [Abstract][Full Text] [Related]
26. A pilot study on pharmacokinetic/pharmacodynamic target attainment in critically ill patients receiving piperacillin/tazobactam.
Martínková J; Malbrain ML; Havel E; Šafránek P; Bezouška J; Kaška M
Anaesthesiol Intensive Ther; 2016; 48(1):23-8. PubMed ID: 26588478
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of continuous-infusion meropenem in a pediatric patient receiving extracorporeal life support.
Cies JJ; Moore WS; Dickerman MJ; Small C; Carella D; Chopra A; Parker J
Pharmacotherapy; 2014 Oct; 34(10):e175-9. PubMed ID: 25146254
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y
Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133
[TBL] [Abstract][Full Text] [Related]
29. Comparison of two empiric antibiotic regimen in late onset neonatal sepsis--a randomized controlled trial.
Ramasamy S; Biswal N; Bethou A; Mathai B
J Trop Pediatr; 2014 Feb; 60(1):83-6. PubMed ID: 24064510
[TBL] [Abstract][Full Text] [Related]
30. Early vancomycin, amikacin and gentamicin concentrations in pulmonary artery and pulmonary tissue are not affected by VA ECMO (venoarterial extracorporeal membrane oxygenation) in a pig model of prolonged cardiac arrest.
Bělohlávek J; Springer D; Mlček M; Huptych M; Bouček T; Hodková G; Fichtl J; Mrázek V; Zima T; Linhart A; Kittnar O
Pulm Pharmacol Ther; 2013 Dec; 26(6):655-60. PubMed ID: 23524014
[TBL] [Abstract][Full Text] [Related]
31. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
[TBL] [Abstract][Full Text] [Related]
32. Covariate determinants of effective dosing regimens for time-dependent beta-lactam antibiotics for critically ill patients.
Kaska M; Havel E; Selke-Krulichova I; Safranek P; Bezouska J; Martinkova J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep; 162(3):219-226. PubMed ID: 29582860
[TBL] [Abstract][Full Text] [Related]
33. Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen.
de Montmollin E; Bouadma L; Gault N; Mourvillier B; Mariotte E; Chemam S; Massias L; Papy E; Tubach F; Wolff M; Sonneville R
Intensive Care Med; 2014 Jul; 40(7):998-1005. PubMed ID: 24687298
[TBL] [Abstract][Full Text] [Related]
34. The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study.
Shekar K; Fraser JF; Taccone FS; Welch S; Wallis SC; Mullany DV; Lipman J; Roberts JA;
Crit Care; 2014 Dec; 18(6):565. PubMed ID: 25636084
[TBL] [Abstract][Full Text] [Related]
35. Effect of analytical inaccuracy on dose adjustment for gentamicin using the Abbottbase Pharmacokinetic Systems.
Bouzas L; Hermida J; Tutor JC
Clin Lab; 2004; 50(3-4):187-91. PubMed ID: 15074474
[TBL] [Abstract][Full Text] [Related]
36. Cefoperazone/sulbactam therapeutic drug monitoring in patients with liver cirrhosis: Potential factors affecting the pharmacokinetic/pharmacodynamic target attainment.
Dong Y; Li Y; Zhang Y; Zhang T; Zhu L; Dong Y; Wang T
Basic Clin Pharmacol Toxicol; 2019 Oct; 125(4):353-359. PubMed ID: 31056857
[TBL] [Abstract][Full Text] [Related]
37. [Monitoring aminoglycosides in an Intensive Care Unit].
Commandeur D; Eyrieux S; Le Noël A; Nguyen VB; Giacardi C; Danguy des Déserts M; Buguet-Brown ML; Drouillard I
Med Mal Infect; 2010 Feb; 40(2):94-9. PubMed ID: 19793633
[TBL] [Abstract][Full Text] [Related]
38. Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis.
Lugo G; Castañeda-Hernández G
Crit Care Med; 1997 May; 25(5):806-11. PubMed ID: 9187600
[TBL] [Abstract][Full Text] [Related]
39. Individualizing piperacillin/tazobactam dosing in adult patients with cystic fibrosis: can tobramycin measurements help?
Crass RL; Pai MP; Lodise TP
J Antimicrob Chemother; 2019 Jan; 74(1):126-129. PubMed ID: 30252050
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic drug monitoring of piperacillin and tazobactam by RP-HPLC of residual blood specimens.
Verhoven SM; Groszek JJ; Fissell WH; Seegmiller A; Colby J; Patel P; Verstraete A; Shotwell M
Clin Chim Acta; 2018 Jul; 482():60-64. PubMed ID: 29596815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]